Leflunomide: A promising drug with good antitumor potential
Chunying Zhang et al, 2018, Biochemical and Biophysical Research Communications CrossRef
Recent advances of human dihydroorotate dehydrogenase inhibitors for cancer therapy: Current development and future perspectives
Lele Zhang et al, 2022, European Journal of Medicinal Chemistry CrossRef
Cell-Based Double-Screening Method to Identify a Reliable Candidate for Osteogenesis-Targeting Compounds
Sho Fukuyasu et al, 2022, Biomedicines CrossRef
Leflunomide Synergizes with Gemcitabine in Growth Inhibition of PC Cells and Impairs c-Myc Signaling through PIM Kinase Targeting
Ralf Buettner et al, 2019, Molecular Therapy - Oncolytics CrossRef
AhR and Cancer: From Gene Profiling to Targeted Therapy
Anaïs Paris et al, 2021, International Journal of Molecular Sciences CrossRef
Drug Repurposing Opportunities in Cancer
Popat Kumbhar et al, 2023, Drug Repurposing for Emerging Infectious Diseases and Cancer CrossRef
Epigenetic landscape of drug responses revealed through large-scale ChIP-seq data analyses
Zhaonan Zou et al, 2022, BMC Bioinformatics CrossRef
A Patent Review of Human Dihydroorotate Dehydrogenase (hDHODH) Inhibitors as Anticancer Agents and their Other Therapeutic Applications (1999-2022)
Pinky Gehlot et al, 2024, Recent Patents on Anti-Cancer Drug Discovery CrossRef
Synthesis, characterization, electrochemical and DNA binding studies of regio-isomeric sulfonyl esters of substituted isoxazoles
Mehwash Zia et al, 2020, Journal of Molecular Structure CrossRef
The Mitochondria-Independent Cytotoxic Effect of Leflunomide on RPMI-8226 Multiple Myeloma Cell Line
Grzegorz Adamczuk et al, 2021, Molecules CrossRef
Revisiting the role of dihydroorotate dehydrogenase as a therapeutic target for cancer
Joseph T. Madak et al, 2019, Pharmacology & Therapeutics CrossRef
Drug repurposing: An emerging strategy in alleviating skin cancer
Popat Kumbhar et al, 2022, European Journal of Pharmacology CrossRef